Literature DB >> 4208469

The effects of the natriuretic factor from uremic urine on sodium transport, water and electrolyte content, and pyruvate oxidation by the isolated toad bladder.

M A Kaplan, J J Bourgoignie, J Rosecan, N S Bricker.   

Abstract

The urine of patients with chronic uremia contains a gel filtration fraction that is natriuretic in the rat. The effects of this fraction on the isolated urinary bladder of the toad were examined in the present studies. When added to the serosal surface of the bladder, a significant and substantial fall in short-circuit current and potential difference was observed. The changes began after a lag period of at least 10 min and continued over a period of 60 min. The decrease in short-circuit current at the end of 1 h averaged 44%. The same fraction from the urine of normal subjects produced no significant change in either short-circuit current or potential difference. When the isolated epithelial cells from the toad bladder were incubated in the presence of the inhibitor, intracellular sodium content increased significantly. There was no change in intracellular water content; hence the intracellular concentration of sodium increased by a mean of 7 meq/liter. The changes in intracellular potassium content and concentration were not satistically significant. When the isolated epithelia were incubated with the uremic factor, there was also a significant decrease in pyruvate utilization in relation to cells from paired hemibladders incubated in the absence of the fraction. The fraction from normal subjects produced no change in either intracellular sodium content or pyruvate oxidation. The results suggest that the inhibitor acts from the serosal surface, inhibits sodium transport across the serosal barrier, and produces a decrease in substrate utilization in association with the change in transepithelial sodium transport.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4208469      PMCID: PMC302652          DOI: 10.1172/JCI107707

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  12 in total

Review 1.  Sodium metabolism.

Authors:  L E Earley; T M Daugharty
Journal:  N Engl J Med       Date:  1969-07-10       Impact factor: 91.245

Review 2.  Tubular reabsorption of sodium ion: influence of factors other than aldosterone and glomerular filtration rate. 1.

Authors:  R W Schrier; H E De Wardener
Journal:  N Engl J Med       Date:  1971-11       Impact factor: 91.245

3.  Inhibition by ammonium of sodium transport across isolated toad bladder.

Authors:  S J Guggenheim; J Bourgoignie; S Klahr
Journal:  Am J Physiol       Date:  1971-06

Review 4.  The control of sodium excretion with normal and reduced nephron populations. The pre-eminence of third factor.

Authors:  N S Bricker
Journal:  Am J Med       Date:  1967-09       Impact factor: 4.965

5.  Action of ouabain on bioelectric properties and ion content in toad urinary bladder.

Authors:  F C Herrera
Journal:  Am J Physiol       Date:  1968-07

6.  Effect of ADH, aldosterone, ouabain, and amiloride on toad bladder epithelial cells.

Authors:  J S Handler; A S Preston; J Orloff
Journal:  Am J Physiol       Date:  1972-05

7.  Amiloride: a potent inhibitor of sodium transport across the toad bladder.

Authors:  P J Bentley
Journal:  J Physiol       Date:  1968-03       Impact factor: 5.182

8.  A natriuretic factor in the serum of patients with chronic uremia.

Authors:  J J Bourgoignie; K H Hwang; C Espinel; S Klahr; N S Bricker
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

9.  Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum.

Authors:  J Bourgoignie; S Klahr; N S Bricker
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808

10.  Isolated epithelial cells of the toad bladder. Their preparation, oxygen consumption, and electrolyte content.

Authors:  J T Gatzy; W O Berndt
Journal:  J Gen Physiol       Date:  1968-06       Impact factor: 4.086

View more
  11 in total

1.  Identification of xanthurenic acid 8-O-beta-D-glucoside and xanthurenic acid 8-O-sulfate as human natriuretic hormones.

Authors:  Christopher D Cain; Frank C Schroeder; Stewart W Shankel; Mark Mitchnick; Michael Schmertzler; Neal S Bricker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-31       Impact factor: 11.205

Review 2.  Endogenous digitalis: pathophysiologic roles and therapeutic applications.

Authors:  Alexei Y Bagrov; Joseph I Shapiro
Journal:  Nat Clin Pract Nephrol       Date:  2008-06-10

Review 3.  Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

Authors:  Alexei Y Bagrov; Joseph I Shapiro; Olga V Fedorova
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

Review 4.  Endogenous cardiotonic steroids in kidney failure: a review and an hypothesis.

Authors:  John M Hamlyn; Paolo Manunta
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

5.  Role of the basal sodium intake in the rats on their response to a natriuretic factor.

Authors:  H Favre; F Louis; M Gourjon
Journal:  Pflugers Arch       Date:  1979-10       Impact factor: 3.657

6.  On the influence of the natriuretic factor from patients with chronic uremia on the bioelectric properties and sodium transport of the isolated mammalian collecting tubule.

Authors:  L G Fine; J J Bourgoignie; K H Hwang; N S Bricker
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

7.  The presence of a natriuretic factor in urine of patients with chronic uremia. The absence of the factor in nephrotic uremic patients.

Authors:  J J Bourgoignie; K H Hwang; E Ipakchi; N S Bricker
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

8.  An inhibitor of sodium transport in the urine of dogs with normal renal function.

Authors:  H Favre; K H Hwang; R W Schmidt; N S Bricker; J J Bourgoignie
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

9.  Natriuretic hormone - a circulating inhibitor of sodium- and potassium-activated adenosine triphosphatase. Its potential role in body fluid and blood pressure regulation.

Authors:  H J Kramer
Journal:  Klin Wochenschr       Date:  1981-11-16

10.  Na-K-adenosine triphosphatase in the kidney of rats with renal hypertension and spontaneously hypertensive rats.

Authors:  Y U Postnov; M Reznikova; G Boriskina
Journal:  Pflugers Arch       Date:  1976-03-11       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.